New Zealand markets closed

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
99.63-0.76 (-0.76%)
At close: 04:00PM EDT
100.27 +0.64 (+0.64%)
After hours: 07:34PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close100.39
Bid99.99 x 900
Ask101.79 x 1000
Day's range99.57 - 100.72
52-week range91.51 - 122.16
Avg. volume1,678,653
Market cap225.619B
Beta (5Y monthly)0.29
PE ratio (TTM)34.12
EPS (TTM)2.92
Earnings dateN/A
Forward dividend & yield1.60 (1.63%)
Ex-dividend date12 Aug 2022
1y target est126.42
  • Zacks

    Top Analyst Reports for Novo Nordisk, Suncor Energy, & Nasdaq

    Today's Research Daily features new research reports on 12 major stocks, including Novo Nordisk A/S (NVO), Suncor Energy Inc. (SU) and Nasdaq, Inc. (NDAQ).

  • Motley Fool

    This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?

    Shares of Eli Lilly (NYSE: LLY) recently ticked higher in response to encouraging words from a Wall Street analyst who follows the pharmaceutical industry. Colin Bristow at UBS, an investment bank, thinks this is the most attractive pharma stock you can buy right now. Is Bristow right about Eli Lilly?

  • GlobeNewswire

    Novo Nordisk A/S – Share repurchase programme

    Bagsværd, Denmark, 26 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme